Trial intelligence / Profile preview

BIAP in moderate to severe ulcerative colitis

NCT00727324Phase 2Completed

Sponsor
AM-Pharma
Start
May 2006
Primary completion
Nov 2006
Modality
Replacement Enzymes
Countries
2
01

Overview

A Phase 2 trial of bovine intestinal alkaline phosphatase in ulcerative colitis (UC), sponsored by AM-Pharma. Started May 2006; status: completed.

02

Drugs

bovine intestinal alkaline phosphatase
03

Conditions

ulcerative colitis (UC)

Beyond the preview

Go deeper on NCT00727324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00727324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call